Paraganglioma — Trials

Paraganglioma — Trials · CancerIndex

Clinical trials

Registered studies

144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03206060	Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma	recruiting	Phase 2	130	National Cancer Institute (NCI)NIH	1	Aug 25, 2026	clinicaltrials
NCT06427798	Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy	recruiting	Phase 1 / Phase 2	66	National Cancer Institute (NCI)NIH	1	Aug 18, 2026